Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
TSBXCompany Name
TURNSTONE BIOLOGICS CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTURNSTONE BIOLOGICS CORP - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TSBX - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -46.04M | 0% | $ 0 |
| 3/31/2025 | $ -61.36M | 0% | $ 0 |
| 12/31/2024 | $ -68.97M | 0% | $ 0 |
| 9/30/2024 | $ -73.22M | 0% | $ 0 |
| 6/30/2024 | $ -72.52M | 0% | $ 0 |
| 3/31/2024 | $ -72.49M | 0% | $ 0 |
| 12/31/2023 | $ -52.69M | -272.91% | $ 19.31M |
| 12/31/2022 | $ -26.79M | -36.55% | $ 73.3M |
Key Performance Insights, Last 5 Years
- TURNSTONE BIOLOGICS CORP's latest trailing twelve months (TTM) EBITDA % stands at -36.55%.
- Over the past 5 years, TURNSTONE BIOLOGICS CORP's average EBITDA % has been -154.73%.
- The median EBITDA % for TURNSTONE BIOLOGICS CORP during this period was -154.73%
- TURNSTONE BIOLOGICS CORP reached its highest EBITDA % over the past 5 years at -36.55%.
- The lowest EBITDA % recorded by TURNSTONE BIOLOGICS CORP in the same timeframe -272.91%
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for TURNSTONE BIOLOGICS CORP is calculated as follows: EBITDA [ $ -26.79M ] / Revenues [ $ 73.3M ]
(=) EBITDA % [ -36.55% ] TSBX - EBITDA Margin, Last 5 years
-272.91%
Minimum
Dec 31, 2023
-36.55%
Maximum
Dec 31, 2022
-154.73%
Average
-154.73%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |